4th Antigen-Specific Immune Tolerance Drug Development

  • 2021 (Not Final)
  • Boston, MA, United States

Description

The 4th Antigen-Specific Immune Tolerance Drug Development is dedicated to safe and effective antigen-specific immune tolerance therapies.

The 4th Antigen-Specific Immune Tolerance Drug Development covers topics such as:

  • Analyzing the Scope & Strategies to Antigen-Specific Immune Tolerance
  • Dynamics of Underlying Causes & Current Understandings of Autoimmunity
  • Improving the Pre-Clinical Predictability of Antigen-Specific Immune Tolerance Therapies
  • Identification, Validation & Targeting of Specific Antigens for Immune Tolerance Therapies
  • Optimizing Clinical Development & Paving the Future of Antigen-Specific Immune Tolerance Therapies
  • Surging Translational Potentials of Pre-Clinical Antigen-Specific Therapies
  • Commercialization: Future Proofing Immune Tolerance Therapies for Patients

The 4th Antigen-Specific Immune Tolerance Drug Development might be held in Boston, MA, United States in 2021 (Not Final).

Venue

Boston,
Massachusetts,
United States
  View all Hotels near Venue

More Details

998-2999 US Dollar
No exhibition
Hanson Wade

Future Events

  • 4th Antigen-Specific Immune Tolerance Drug Development - 2021 (73896)

Past Events

  • 3rd Antigen-Specific Immune Tolerance Drug Development - 25-27 Feb 2020 (81461)
  • 2nd Antigen-Specific Immune Tolerance Drug Development Summit 2019 - 26-28 Mar 2019 (81459)

Important

Please, check the official conference website for possible changes, before you make any traveling arrangements

Prices are for evaluation only.

Other Events with Similar Categories

Featured Conferences & Exhibitions